Prior guidance was $1.03B-$1.095B. Consensus $1.06B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACAD:
- Acadia Pharmaceuticals reports Q2 EPS 16c, consensus 14c
- ACAD Earnings this Week: How Will it Perform?
- Cautious Outlook on ACADIA Pharmaceuticals Amid Market Penetration and Growth Uncertainties
- Taysha Gene Therapies initiated with a Buy at BofA
- Acadia Pharmaceuticals price target raised to $22 from $19 at Oppenheimer